5.7 Serotonin Syndrome Serotonin syndrome, a potentially life-threatening reaction, may occur when amphetamines are used in combination with other drugs that affect the serotonergic neurotransmitter systems such as monoamine oxidase inhibitors (MAOIs), selective serotonin reuptake inhibitors (SSRIs), serotonin norepinephrine reuptake inhibitors (SNRIs), triptans, tricyclic antidepressants, fentanyl, lithium, tramadol, tryptophan, buspirone, and St
Neuroprotective actions of glucagon-like peptide-1 (GLP-1) analogues in alzheimers and parkinsons diseases
The report is segmented by Application (Type 2 diabetes mellitus, Obesity management, and Cardiovascular diseases), Route of Administration (Subcutaneous injection, and Oral administration), Distribution Channel (Hospital pharmacies, Retail pharmacies, and Online pharmacies) and Geography (North America, Europe, Asia, Rest of World (ROW)) Which regions are analyzed in the report
Segerstolpe , Palasantza A, Eliasson P, et al
In July 2025, Biocon Biologics received U.S